Studies on phase variation in Bordetella pertussis. 1985

S Goldman, and E Hanski, and F Fish

Pathogenic strains of Bordetella pertussis undergo spontaneous phase variation and become non-pathogenic upon culturing in vitro. The spontaneous process was studied in pathogenic B. pertussis strains Tohama, 165 and 18323 by isolating spontaneous variants, selected for their ability to grow on synthetic and semi-synthetic solid media. In strains Tohama and 165, the frequency of variants able to grow on synthetic and semi-synthetic media was between 10(-6) and 10(-7). About 250 variant strains were screened for the presence of virulence-associated traits, such as production of hemolysin, pertussis toxin and filamentous hemagglutinin (FHA). Only four different combinations of the traits were found: 7-11% of the variants displayed all traits, 17% of the variants carried pertussis toxin and FHA, 5-11% carried FHA only and 66% were devoid of all virulence traits. The strains which had at least one virulence trait also demonstrated some adenylate cyclase activity. The disappearance of hemolysin was related quantitatively to the other traits. These results suggest that phase variation in B. pertussis is a non random process, involving ordered disappearance of virulence factors in the following order: hemolysin, pertussis toxin and FHA. Since all the variant strains were phenotypically stable upon further passaging in vitro, they represent the stable, final outcome of the variation process which may have occurred in "Phase I" colonies. In contrast, 300 variants of B. pertussis 18323, which were able to grow on selective solid media, carried all the virulence traits. This is in accordance with the strain's unique intracerebral virulence.

UI MeSH Term Description Entries
D010566 Virulence Factors, Bordetella A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor. Bordetella Virulence Factors,Agglutinogen 2, Bordetella Pertussis,Bordetella Virulence Determinant,LFP-Hemagglutinin,LP-HA,Leukocytosis-Promoting Factor Hemagglutinin,Lymphocytosis-Promoting Factor-Hemagglutinin,Pertussis Agglutinins,Agglutinins, Pertussis,Determinant, Bordetella Virulence,Factor Hemagglutinin, Leukocytosis-Promoting,Factor-Hemagglutinin, Lymphocytosis-Promoting,Factors, Bordetella Virulence,Hemagglutinin, Leukocytosis-Promoting Factor,LFP Hemagglutinin,LP HA,Leukocytosis Promoting Factor Hemagglutinin,Lymphocytosis Promoting Factor Hemagglutinin,Virulence Determinant, Bordetella
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001886 Bordetella pertussis A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Bacterium tussis-convulsivae,Haemophilus pertussis,Hemophilus pertussis
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006460 Hemolysin Proteins Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS. Hemolysin,Hemolysins,Hemalysins,Proteins, Hemolysin
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D037342 Pertussis Toxin One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity. IAP Pertussis Toxin,Islet-Activating Protein,Pertussigen,Histamine-Sensitizing Factor,Islets-Activating Protein,Lymphocytosis-Promoting Factor,Histamine Sensitizing Factor,Islet Activating Protein,Islets Activating Protein,Lymphocytosis Promoting Factor,Pertussis Toxin, IAP,Toxin, IAP Pertussis,Toxin, Pertussis

Related Publications

S Goldman, and E Hanski, and F Fish
January 1987, Medical microbiology and immunology,
S Goldman, and E Hanski, and F Fish
September 1969, Japanese journal of microbiology,
S Goldman, and E Hanski, and F Fish
October 1967, The Journal of pathology and bacteriology,
S Goldman, and E Hanski, and F Fish
January 1988, The Tokai journal of experimental and clinical medicine,
S Goldman, and E Hanski, and F Fish
May 2007, BMC genomics,
S Goldman, and E Hanski, and F Fish
May 1987, Microbial pathogenesis,
S Goldman, and E Hanski, and F Fish
September 1990, The EMBO journal,
S Goldman, and E Hanski, and F Fish
January 2015, PloS one,
S Goldman, and E Hanski, and F Fish
May 1961, Nihon saikingaku zasshi. Japanese journal of bacteriology,
S Goldman, and E Hanski, and F Fish
July 2009, Expert review of vaccines,
Copied contents to your clipboard!